Pathology: mBC - TNBC - L1 - all population; mBC - TNBC - L1 - PDL1 positive;
mBC - TNBC - L1 - all population | mBC - TNBC - L1 - PDL1 positive | |||
KEYNOTE-355 (all population), 2020 | KEYNOTE-355 (CPS>1), 2020 | KEYNOTE-355 (CPS>10), 2020 | ||
pembrolizumab plus SoC | 3 | T1 | T1 | T1 |
placebo plus SoC | 0 | T0 | T0 | T0 |